Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11.
Published April 5, 2023 · Recall initiated: March 2, 2023
Summary
FDA records drug Class II recall D-0475-2023, published April 5, 2023 and initiated March 2, 2023. Recalling firm: Endo Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 372,938 bottles; Lot: Lot #: 34770301, exp. date Mar-23; 34770401, exp. date May-23; 12981201, exp. date Nov-23; 13037201, exp. date Dec-23; 13037301, 13647801, exp. date Feb-24; 13722101, exp. date Mar-24; 13980101, 13980001, exp. date Apr-24; 14461701, 14461801, exp. date Jul-24; 14706201, exp. date Aug-24; 14935601, exp. date Oct-24; 5500131A, 5500132A, exp. date Mar-25. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email if CALCITONIN SALMON has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CALCITONIN SALMON
- Manufacturer
- Endo Pharmaceuticals, Inc.
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot #: 34770301, exp. date Mar-23; 34770401, exp. date May-23; 12981201, exp. date Nov-23; 13037201, exp. date Dec-23; 13037301, 13647801, exp. date Feb-24; 13722101, exp. date Mar-24; 13980101, 13980001, exp. date Apr-24; 14461701, 14461801, exp. date Jul-24; 14706201, exp. date Aug-24; 14935601, exp. date Oct-24; 5500131A, 5500132A, exp. date Mar-25
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACalcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 USP CalcitoninMay 17, 2023
- FDAMontelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC 61919-0009-30;April 5, 2023
- FDAFinasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged andApril 5, 2023
- FDAG7 Acetabular System, Dual Mobility Acetabular Liner, 40 mm, Size D, Model Number 110024462March 29, 2023
- FDAAttune Revision Limb Preservation System (LPS) Tibial Insert SM 12MM, Part Number 151760312March 29, 2023
- FDAAttune Revision Limb Preservation System (LPS) Tibial Insert XSM 12MM, Part Number 151760212March 29, 2023
Questions about this recall
Was Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11. recalled?
Yes. FDA published recall D-0475-2023 on April 5, 2023. Reported hazard: Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CALCITONIN SALMON.